Medical professionals who live with MS are especially able to   more »

A year after it was pulled for safety concerns, a promising treatment for multiple sclerosis seems poised to return. The drug, Tysabri, was pulled off the market last February, after two patients developed a rare brain disorder, known as progressive multifocal leukoencephalopathy, or PML. A third case was later found in a trial that was testing the drug for Crohn’s disease, another immune disorder. Two of the patients eventually died from   more »

Pregnancy and parenting

With new knowledge in this area, we now know that the question is no longer “Can I have a baby?” but “Should ...   more »